 | • レポートコード：MRC23Q35931 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の分散型臨床試験（DCT）市場について調査・分析し、世界の分散型臨床試験（DCT）市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（インターベンショナル、オブザーバー、エクスパンデッドアクセス）、用途別セグメント分析（がん、循環器、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Medidata、IQVIA、Labcorp、PRA Health Sciences、Parexel、ICON、Oracle、CRF Health、Clinical Ink、Medable、Science 37などが含まれています。世界の分散型臨床試験（DCT）市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、分散型臨床試験（DCT）市場規模を推定する際に考慮しました。本レポートは、分散型臨床試験（DCT）の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、分散型臨床試験（DCT）に関するビジネス上の意思決定に役立てることを目的としています。 ・分散型臨床試験（DCT）市場の概要 - 分散型臨床試験（DCT）のタイプ別セグメント - 世界の分散型臨床試験（DCT）市場規模：タイプ別分析（インターベンショナル、オブザーバー、エクスパンデッドアクセス） - 分散型臨床試験（DCT）の用途別セグメント - 世界の分散型臨床試験（DCT）市場規模：用途別分析（がん、循環器、その他） - 世界の分散型臨床試験（DCT）市場規模予測（2018年-2029年） ・分散型臨床試験（DCT）市場の成長トレンド - 分散型臨床試験（DCT）の地域別市場規模（2018年-2029年） - 分散型臨床試験（DCT）市場ダイナミクス - 分散型臨床試験（DCT）の業界動向 - 分散型臨床試験（DCT）市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：インターベンショナル、オブザーバー、エクスパンデッドアクセス - 世界の分散型臨床試験（DCT）のタイプ別市場規模（2018年-2023年） - 世界の分散型臨床試験（DCT）のタイプ別市場規模（2024年-2029年） ・用途別セグメント：がん、循環器、その他 - 世界の分散型臨床試験（DCT）の用途別市場規模（2018年-2023年） - 世界の分散型臨床試験（DCT）の用途別市場規模（2024年-2029年） ・分散型臨床試験（DCT）の地域別市場規模 - 北米の分散型臨床試験（DCT）市場規模（2018年-2029年） - アメリカの分散型臨床試験（DCT）市場規模（2018年-2029年） - ヨーロッパの分散型臨床試験（DCT）市場規模（2018年-2029年） - アジア太平洋の分散型臨床試験（DCT）市場規模（2018年-2029年） - 中国の分散型臨床試験（DCT）市場規模（2018年-2029年） - 日本の分散型臨床試験（DCT）市場規模（2018年-2029年） - 韓国の分散型臨床試験（DCT）市場規模（2018年-2029年） - インドの分散型臨床試験（DCT）市場規模（2018年-2029年） - オーストラリアの分散型臨床試験（DCT）市場規模（2018年-2029年） - 中南米の分散型臨床試験（DCT）市場規模（2018年-2029年） - 中東・アフリカの分散型臨床試験（DCT）市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Medidata、IQVIA、Labcorp、PRA Health Sciences、Parexel、ICON、Oracle、CRF Health、Clinical Ink、Medable、Science 37 ・アナリストの観点/結論 ・調査方法とデータソース |
The FDA defines decentralized clinical trials as those executed through telemedicine and mobile or local healthcare providers, using processes and technologies that differ from the traditional clinical trial model.
Decentralized clinical trials are conducted remotely, with patient subjects remaining at home during a significant portion, or all, of the study. However, the decentralized clinical trial model is designed for more just patient participants.
Highlights
The global Decentralized Clinical Trials (DCTs) market was valued at US$ 8280.7 million in 2022 and is anticipated to reach US$ 18950 million by 2029, witnessing a CAGR of 14.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Decentralized Clinical Trials (DCTs) key players include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. Global top five manufacturers hold a share over 45%.
North America is the largest production region, with a share about 60%, followed by Europe and Asia-Pacific, both have a share over 30 percent. In terms of product, Interventional is the largest segment, with a share over 45%. And in terms of application, the largest application is Oncology, followed by Cardiovascular, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Decentralized Clinical Trials (DCTs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decentralized Clinical Trials (DCTs).
The Decentralized Clinical Trials (DCTs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Decentralized Clinical Trials (DCTs) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decentralized Clinical Trials (DCTs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Medidata
IQVIA
Labcorp
PRA Health Sciences
Parexel
ICON
Oracle
CRF Health
Clinical Ink
Medable
Science 37
Segment by Type
Interventional
Observational
Expanded Access
Segment by Application
Oncology
Cardiovascular
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Decentralized Clinical Trials (DCTs) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Interventional
1.2.3 Observational
1.2.4 Expanded Access
1.3 Market by Application
1.3.1 Global Decentralized Clinical Trials (DCTs) Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Decentralized Clinical Trials (DCTs) Market Perspective (2018-2029)
2.2 Decentralized Clinical Trials (DCTs) Growth Trends by Region
2.2.1 Global Decentralized Clinical Trials (DCTs) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Decentralized Clinical Trials (DCTs) Historic Market Size by Region (2018-2023)
2.2.3 Decentralized Clinical Trials (DCTs) Forecasted Market Size by Region (2024-2029)
2.3 Decentralized Clinical Trials (DCTs) Market Dynamics
2.3.1 Decentralized Clinical Trials (DCTs) Industry Trends
2.3.2 Decentralized Clinical Trials (DCTs) Market Drivers
2.3.3 Decentralized Clinical Trials (DCTs) Market Challenges
2.3.4 Decentralized Clinical Trials (DCTs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue
3.1.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue (2018-2023)
3.1.2 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Players (2018-2023)
3.2 Global Decentralized Clinical Trials (DCTs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Decentralized Clinical Trials (DCTs) Revenue
3.4 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio
3.4.1 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Decentralized Clinical Trials (DCTs) Revenue in 2022
3.5 Decentralized Clinical Trials (DCTs) Key Players Head office and Area Served
3.6 Key Players Decentralized Clinical Trials (DCTs) Product Solution and Service
3.7 Date of Enter into Decentralized Clinical Trials (DCTs) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Decentralized Clinical Trials (DCTs) Breakdown Data by Type
4.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Type (2018-2023)
4.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2024-2029)
5 Decentralized Clinical Trials (DCTs) Breakdown Data by Application
5.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Application (2018-2023)
5.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
6.2 North America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
6.4 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
7.2 Europe Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
7.4 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
8.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2018-2023)
8.4 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
9.2 Latin America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
9.4 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size (2018-2029)
10.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2018-2023)
10.4 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medidata
11.1.1 Medidata Company Detail
11.1.2 Medidata Business Overview
11.1.3 Medidata Decentralized Clinical Trials (DCTs) Introduction
11.1.4 Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2018-2023)
11.1.5 Medidata Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Detail
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Decentralized Clinical Trials (DCTs) Introduction
11.2.4 IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2018-2023)
11.2.5 IQVIA Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Detail
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Decentralized Clinical Trials (DCTs) Introduction
11.3.4 Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2018-2023)
11.3.5 Labcorp Recent Development
11.4 PRA Health Sciences
11.4.1 PRA Health Sciences Company Detail
11.4.2 PRA Health Sciences Business Overview
11.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Introduction
11.4.4 PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2018-2023)
11.4.5 PRA Health Sciences Recent Development
11.5 Parexel
11.5.1 Parexel Company Detail
11.5.2 Parexel Business Overview
11.5.3 Parexel Decentralized Clinical Trials (DCTs) Introduction
11.5.4 Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2018-2023)
11.5.5 Parexel Recent Development
11.6 ICON
11.6.1 ICON Company Detail
11.6.2 ICON Business Overview
11.6.3 ICON Decentralized Clinical Trials (DCTs) Introduction
11.6.4 ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2018-2023)
11.6.5 ICON Recent Development
11.7 Oracle
11.7.1 Oracle Company Detail
11.7.2 Oracle Business Overview
11.7.3 Oracle Decentralized Clinical Trials (DCTs) Introduction
11.7.4 Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2018-2023)
11.7.5 Oracle Recent Development
11.8 CRF Health
11.8.1 CRF Health Company Detail
11.8.2 CRF Health Business Overview
11.8.3 CRF Health Decentralized Clinical Trials (DCTs) Introduction
11.8.4 CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2018-2023)
11.8.5 CRF Health Recent Development
11.9 Clinical Ink
11.9.1 Clinical Ink Company Detail
11.9.2 Clinical Ink Business Overview
11.9.3 Clinical Ink Decentralized Clinical Trials (DCTs) Introduction
11.9.4 Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2018-2023)
11.9.5 Clinical Ink Recent Development
11.10 Medable
11.10.1 Medable Company Detail
11.10.2 Medable Business Overview
11.10.3 Medable Decentralized Clinical Trials (DCTs) Introduction
11.10.4 Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2018-2023)
11.10.5 Medable Recent Development
11.11 Science 37
11.11.1 Science 37 Company Detail
11.11.2 Science 37 Business Overview
11.11.3 Science 37 Decentralized Clinical Trials (DCTs) Introduction
11.11.4 Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2018-2023)
11.11.5 Science 37 Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details